CureSearch Research Programs: Request for Applications
At CureSearch, we’re doing things differently to change the status quo in the pediatric cancer realm. Through our research programs, we fund early-stage research, translational research and pediatric cancer clinical trials with the highest potential. By encompassing all stages of the drug development continuum, our research programs drive critical pediatric research to the children who need it most.
2019 Funding Opportunity Announcement
CureSearch for Children’s Cancer has released a request for applications (RFA) for CureSearch’s three research programs. CureSearch will fund high potential projects that address areas of high, unmet needs in pediatric cancer, driving the development of better, less-toxic children’s cancer treatments.
Awards will support promising early-stage research, translational research and pediatric cancer phase I and II clinical trials with the highest potential of addressing the unmet needs in pediatric oncology drug development. This would include areas such as high-risk, relapsed, or metastatic disease, adolescent and young adult patient populations and/or the use of novel immunotherapy targets or modalities for pediatric cancer treatment.
The application window opened on October 5, 2018 and Letters of Intent (LOIs) are to be submitted by November 16, 2018. Top applicants based on a LOI review will be invited to submit full applications by February 1, 2019; award notifications will be released in March 2019. Letters of Intent can be submitted through ProposalCENTRAL for the following opportunities:
|Program||Opportunity Summary||RFA||Submission Site|
|Young Investigator||An opportunity for funding up to $75,000 in direct costs per year for up to three years (including a 10% indirect cost). Young Investigator Awards provides seed funding for bright researchers, early in their careers, pursuing novel research in pediatric oncology.||Young Investigator Submission Site|
|Acceleration Initiative||An opportunity for funding in the range of $500,000 – $2 million. The Acceleration Initiative funds scientific or technological innovation with the highest likelihood of identifying a breakthrough in childhood cancer treatments and becoming an impactful therapeutic option for children in the near term.||Acceleration Initiative Submission Site|
|Catapult Awards||An opportunity for funding in the range of $2 million to $5 million (USD) opportunity. The award will support the advancement of clinical research in immunotherapy to improve outcomes for pediatric cancer patients. In order to qualify, Phase 1 and Phase 2 pediatric clinical trial projects must be “clinic-ready.”||Catapult Awards Submission Site|
Funding will be provided for up to three years, contingent on demonstration of satisfactory and timely completion of milestones.
At CureSearch for Children’s Cancer, we’re not here just to fund children’s cancer research, we are here to save children. Read more about our research vision.
Please email Caitlyn Barrett, PhD, National Director of Research and Programs, with any questions or comments.